scispace - formally typeset
Journal ArticleDOI

Mutations in the PTEN tumor suppressor gene in cervical carcinomas

Reads0
Chats0
TLDR
Although mutations in the PTEN gene are found in only a small fraction of cervical cancers, alterations of this tumor suppressor gene may play a role in the development of some of these cancers.
Abstract
Maxwell GL, Risinger JI, Shaw H, Alvarez A, Barrett JC, Futreal A, Berchuck A Mutations in the PTEN tumor suppressor gene in cervical carcinomas Int J Gynecol Cancer 1998; 8: 489–493 To elucidate further the molecular pathogenesis of cervical cancer we sought to determine whether mutations in the PTEN tumor suppressor gene are a feature of these cancers Genomic DNA was extracted from 67 primary cervical cancers and 9 immortalized cervical cancer cell lines Using the polymerase chain reaction, the nine exons and intronic splice sites of the PTEN gene were amplified using 11 primer pairs Single strand conformation polymorphism analysis was used to screen for mutations in the PTEN gene and variant bands were subjected to DNA sequencing The primary cancers were also tested for the presence of HPV DNA Mutations in the PTEN gene were not detected in any of the immortalized cell lines, but sequence alterations were noted in 4/67 (6%) primary cervical cancers Three mutations resulted in frameshifts that predict truncated protein products, including two cases in which we found an identical 4-base-pair deletion in codons 318–319 In addition, a one-base-pair insertion in codon 320 was seen in another case Finally, a missense mutation (G143 A) was observed immediately adjacent to the catalytic site of the phosphatase domain in exon 5 In two cases with PTEN mutations in which corresponding normal DNA was available, loss of the wild type allele was demonstrated There was no apparent relationship between the presence of a PTEN mutation and pathologic features or the presence of human papillomavirus DNA Although mutations in the PTEN gene are found in only a small fraction of cervical cancers, alterations of this tumor suppressor gene may play a role in the development of some of these cancers

read more

Citations
More filters

P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase (cancerytyrosine phosphorylationysignal transductionyprotein tyrosine phosphatase)

TL;DR: In this article, the authors showed that recombinant P-TEN dephosphorylated protein and peptide substrates phosphorylated on serine, threonine, and tyrosine residues.
Journal ArticleDOI

Abnormal distribution of hDlg and PTEN in premalignant lesions and invasive cervical cancer

TL;DR: The results suggest that the abnormal expression and localization of PTEN during cervical carcinogenesis may be a consequence of modifications in the expression patterns of hDlg.
References
More filters
Journal ArticleDOI

Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome

TL;DR: Mutational analysis of PTEN in CD kindreds has identified germline mutations that are predicted to disrupt the protein tyrosine/dual-specificity phosphatase domain of this gene, and implies that PTEN may play a role in organizing the relationship of different cell types within an organ during development.
Journal ArticleDOI

P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase

TL;DR: It is demonstrated that mutations in P-TEN, identified from primary tumors, tumor cells lines, and a patient with Bannayan-Zonana syndrome, resulted in the ablation of phosphatase activity, demonstrating that enzymatic activity of P- TEN is necessary for its ability to function as a tumor suppressor.
Journal Article

Frequent Inactivation of PTEN/MMAC1 in Primary Prostate Cancer

TL;DR: The identification of the second mutational event in 10 (43%) tumors establishes PTEN/MMAC1 as a main inactivation target of 10q loss in sporadic prostate cancer.
Related Papers (5)